Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bone Marrow Metastases
Tc-99m-MIBI used to detect bone marrow metastases in childhood solid tumors
February 8th, 2006
Tc-99m-hexakis-2-methoxyisobutylisonitrile (Tc-99m-MIBI) could be used to detect bone marrow metastases in childhood solid tumors. Researchers in Turkey conducted a study "to evaluate the role of Tc-99m-MIBI for detecting bone marrow metastases in childhood solid tumors, including lymphomas. Twenty-six children (118 males, 8 females) were studied." "They all had proven malignant solid tumors [Hodgkin lymphoma (5), non-Hodgkin lymphoma (3), neuroblastoma (9), Ewing sarcoma (3), Langerhans cell histiocytosis (4), rhabdomyosarcoma (1) and germ cell tumor (1)] with suspected bone marrow metastases. All patients underwent computed tomography and/or...
Source: Immunotherapy Weekly (2006-02-08)
|
